A cost-effectiveness analysis of Molnupiravir and Paxlovid for outpatient treatment of COVID-19 in three African countries

Background: Two COVID-19 oral antivirals (COAVs), Molnupiravir and Paxlovid, have been shown to be cost-effective in high-income countries. Aim: This study assesses the cost-effectiveness of Paxlovid and Molnupiravir, compared to usual care in three African countries. Setting: The study was conduc...

Full description

Saved in:
Bibliographic Details
Main Authors: Ijeoma P. Edoka, Tom Drake, Peter Baker, Raji Tajudeen, Elias Asfaw, Javier Guzman, Nicaise Ndembi, Justice Nonvignon, Jean Kaseya
Format: Article
Language:English
Published: AOSIS 2025-06-01
Series:Journal of Public Health in Africa
Subjects:
Online Access:https://publichealthinafrica.org/index.php/jphia/article/view/805
Tags: Add Tag
No Tags, Be the first to tag this record!